GW PHARMACEUTICALS PLC Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
GW PHARMACEUTICALS PLC had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $21.60 million as of 2020-12-31, per its 10-K filed 2021-02-26.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2021-02-26
- 2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $21.60M.
- 2019-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $12.50M.
- 2018-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $9.80M.
- 2018-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $16.90M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value |
|---|---|
| 2020-12-31 | $21.60M 10-K · filed 2021-02-26 |
| 2019-12-31 | $12.50M 10-K · filed 2020-02-27 |
| 2018-12-31 | $9.80M 10-KT · filed 2019-02-28 |
| 2018-09-30 | $16.90M 10-K · filed 2018-11-29 |